跳至主要内容
临床试验/CTRI/2024/08/072577
CTRI/2024/08/072577已完成2 期

A Double Blind Randomized Comparative Clinical Trial of Herbal Preparation (Laxoherb Kid SyrupR) with Dietary Regulation and Toilet Training for the Management of Functional Constipation in Children

Jupiter Pharmaceuticals Limited1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年9月2日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
The effect of Laxoherb Kid Syrup in the management of Vibandha (Functional constipation) in children

研究概览

简要总结

Constipation in children is defined as a delay or difficulty in defecation resent for two or more weeks. According to Ayurveda “Vibandha” is among the commonest clinical conditions in children with difficulty defecating, hard stools, and infrequent bowel movements. The current trial is proposed to study the effect of Laxoherb Kid Syrup by using specific parameters for Vibandha w.s.r. to functional constipation. The objective of the present study is to evaluate the effect of Laxoherb Kid Syrup in the management of Vibandha (Functional constipation) in children. The children of either gender between the age group of 02-16 years fulfilling the diagnostic criteria of functional constipation, whose parents are willing to give consent, will be registered for the clinical study. The test drug, Laxoherb Kid Syrup will be given in two groups (a) age 2-8 yrs. at the dose of 5 ml twice daily orally for 15 days and (b) age 9-16 yrs. at the dose of 10 ml thrice daily orally for 15 days. The placebo will be given at the same dose without active ingredients. The assessment will be done following the ROME III criteria and Bristol criteria for functional constipation depending upon the age of the child at day 15. The safety blood profile will also be checked. The data collected before and after the intervention within the group and between the groups will be recorded and evaluated using non-parametric statistical methods (Wilcoxon signed rank test, Mann Whitney test and Chi-square test which will be applicable.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
2.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • The children of either gender between the age group of 02-16 years fulfilling the diagnostic criteria of functional constipation, whose parents are willing to give consent, will be registered for the clinical study.

排除标准

  • Children having constipation secondary to any of the other diseases like hypothyroidism, hirschprung’s disease and structural anomalies of anal canal will be excluded from the trial based on clinical presentations.

结局指标

主要结局

The effect of Laxoherb Kid Syrup in the management of Vibandha (Functional constipation) in children

时间窗: 15 days

次要结局

  • Compare the effect of trial drugs with respect to placebo drug, dietary regulation and toilet training(15 days)

研究者

发起方
Jupiter Pharmaceuticals Limited
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Achyut Bhattacharyya

Professor, Department of Kaumarbhritya

研究点 (1)

Loading locations...

相似试验